Trevena's Series B Round

Trevena raised a round of funding on July 15, 2010.

Trevena is a clinical stage pharmaceutical company focused on discovering and developing the next generation of G protein coupled receptor (GPCR) targeted medicines. Despite the past success of GPCR d…

Articles about Trevena's Series B Round: